ATE249454T1 - Substituierte benzo(b)thiophene als selektive östrogenrezeptormodulatoren - Google Patents
Substituierte benzo(b)thiophene als selektive östrogenrezeptormodulatorenInfo
- Publication number
- ATE249454T1 ATE249454T1 AT97308412T AT97308412T ATE249454T1 AT E249454 T1 ATE249454 T1 AT E249454T1 AT 97308412 T AT97308412 T AT 97308412T AT 97308412 T AT97308412 T AT 97308412T AT E249454 T1 ATE249454 T1 AT E249454T1
- Authority
- AT
- Austria
- Prior art keywords
- estrogen
- compounds
- progestin
- alkyl
- nitrogen
- Prior art date
Links
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 title 1
- 239000000333 selective estrogen receptor modulator Substances 0.000 title 1
- 229940095743 selective estrogen receptor modulator Drugs 0.000 title 1
- 229930192474 thiophene Natural products 0.000 title 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000000262 estrogen Substances 0.000 abstract 3
- 229940011871 estrogen Drugs 0.000 abstract 3
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 239000000583 progesterone congener Substances 0.000 abstract 2
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 abstract 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 abstract 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 abstract 1
- 125000005129 aryl carbonyl group Chemical group 0.000 abstract 1
- 125000005199 aryl carbonyloxy group Chemical group 0.000 abstract 1
- 125000005200 aryloxy carbonyloxy group Chemical group 0.000 abstract 1
- 125000001246 bromo group Chemical group Br* 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 150000003950 cyclic amides Chemical group 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 150000003949 imides Chemical class 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2905696P | 1996-10-25 | 1996-10-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE249454T1 true ATE249454T1 (de) | 2003-09-15 |
Family
ID=21846972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97308412T ATE249454T1 (de) | 1996-10-25 | 1997-10-22 | Substituierte benzo(b)thiophene als selektive östrogenrezeptormodulatoren |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5962475A (OSRAM) |
| EP (1) | EP0838464B1 (OSRAM) |
| JP (1) | JPH10204082A (OSRAM) |
| AT (1) | ATE249454T1 (OSRAM) |
| CA (1) | CA2218756A1 (OSRAM) |
| DE (1) | DE69724733T2 (OSRAM) |
| ES (1) | ES2206664T3 (OSRAM) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2236007A1 (en) | 1995-10-31 | 1997-07-17 | Gerald Floyd Smith | Antithrombotic diamines |
| WO2001026651A2 (en) * | 1999-10-14 | 2001-04-19 | Endorecherche, Inc. | Selective estrogen receptor modulators in the treatment or reduction of the risk of acquiring hypertension, cardiovascular diseases, and insulin resistance |
| AU7993500A (en) * | 1999-11-15 | 2001-05-30 | New Millennium Pharmaceutical Research, Inc. | Intranasal administration of raloxifene and tamoxifen |
| US6471979B2 (en) | 1999-12-29 | 2002-10-29 | Estrogen Vascular Technology, Llc | Apparatus and method for delivering compounds to a living organism |
| WO2001047451A1 (en) * | 1999-12-29 | 2001-07-05 | Gishel New | Apparatus and method for delivering compounds to a living organism |
| AU2002235348A1 (en) * | 2001-01-17 | 2002-07-30 | Praecis Pharmaceuticals Inc. | Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators |
| PL366453A1 (en) * | 2001-05-01 | 2005-02-07 | Pfizer Products Inc. | Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency |
| PT1401446E (pt) * | 2001-05-22 | 2005-05-31 | Lilly Co Eli | Derivados de tetrahidroquinolina para a inibicao de doencas associadas com a privacao de estrogenio ou com uma resposta fisiologica aberrante ao estrogenio endogeno |
| WO2002094788A1 (en) | 2001-05-22 | 2002-11-28 | Eli Lilly And Company | 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| HUP0401268A2 (hu) | 2001-07-31 | 2004-11-29 | Pfizer Products Inc. | Ösztrogén agonisták/antagonisták, ösztrogének és progesztinek kombinációját tartalmazó gyógyszerkészítmények, valamint eljárás ezek előállítására |
| BR0312675A (pt) | 2002-07-22 | 2005-05-03 | Lilly Co Eli | Composto ou um sal de adição de ácido farmacêutico do mesmo,m e, métodos para tratar endometriose, e para tratar leiomioma uterino |
| EP3608317A1 (en) * | 2012-01-12 | 2020-02-12 | Yale University | Compounds & methods for the enhanced degradation of targeted proteins & other polypeptides by an e3 ubiquitin ligase |
| ES2774935T3 (es) | 2012-10-24 | 2020-07-23 | Univ Illinois | Composiciones y métodos para tratar trastornos médicos relacionados con estrógeno |
| WO2014066695A1 (en) | 2012-10-24 | 2014-05-01 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating estrogen-related medical disorders |
| JP6644268B2 (ja) * | 2018-03-22 | 2020-02-12 | 横浜ゴム株式会社 | タイヤ用ゴム組成物及びスタッドレスタイヤ |
| JP7085056B2 (ja) * | 2018-07-12 | 2022-06-15 | イーライ リリー アンド カンパニー | 選択的エストロゲン受容体分解剤 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH18628A (en) * | 1981-04-03 | 1985-08-23 | Lilly Co Eli | "6-hydroxy-2-(4-hydroxyphenyl)-3 4-(2- piperidine or 3-methylpyrollidine -benzo b thiophene compounds |
| JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
| TW366342B (en) * | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
| US5482949A (en) * | 1993-03-19 | 1996-01-09 | Eli Lilly And Company | Sulfonate derivatives of 3-aroylbenzo[b]thiophenes |
| US6756388B1 (en) * | 1993-10-12 | 2004-06-29 | Pfizer Inc. | Benzothiophenes and related compounds as estrogen agonists |
| US5484798A (en) * | 1994-09-20 | 1996-01-16 | Eli Lilly And Company | Benzothiopene compounds, compositions, and method of inhibiting restenosis |
| US6703407B1 (en) * | 1994-09-20 | 2004-03-09 | Eli Lilly And Company | Benzofuran compounds, compositions, and methods |
| US5589482A (en) * | 1994-12-14 | 1996-12-31 | Pfizer Inc. | Benzo-thiophene estrogen agonists to treat prostatic hyperplasia |
| US5552401A (en) * | 1995-02-28 | 1996-09-03 | Eli Lilly And Company | 2-benzyl-3-arylbenzothiophenes |
| US5705507A (en) * | 1995-03-10 | 1998-01-06 | Eli Lilly And Company | Aplha-substituted-3-benzyl-benzofurans |
| WO1996032937A1 (en) * | 1995-04-21 | 1996-10-24 | Eli Lilly And Company | Benzothiophenes with novel basic side chains |
-
1997
- 1997-10-20 CA CA002218756A patent/CA2218756A1/en not_active Abandoned
- 1997-10-20 JP JP9325116A patent/JPH10204082A/ja not_active Withdrawn
- 1997-10-22 DE DE69724733T patent/DE69724733T2/de not_active Expired - Fee Related
- 1997-10-22 AT AT97308412T patent/ATE249454T1/de not_active IP Right Cessation
- 1997-10-22 EP EP97308412A patent/EP0838464B1/en not_active Expired - Lifetime
- 1997-10-22 ES ES97308412T patent/ES2206664T3/es not_active Expired - Lifetime
- 1997-10-23 US US08/956,802 patent/US5962475A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH10204082A (ja) | 1998-08-04 |
| DE69724733D1 (de) | 2003-10-16 |
| ES2206664T3 (es) | 2004-05-16 |
| CA2218756A1 (en) | 1998-04-25 |
| DE69724733T2 (de) | 2004-07-08 |
| US5962475A (en) | 1999-10-05 |
| EP0838464B1 (en) | 2003-09-10 |
| EP0838464A1 (en) | 1998-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69724733D1 (de) | Substituierte Benzo(b)thiophene als selektive Östrogenrezeptormodulatoren | |
| NZ334547A (en) | Hetaroyl cyclohexanedione derivatives with herbicidal effect | |
| AR045180A1 (es) | Derivados 3-amino cromado y 2-amino tetralina y composiciones que contienen a dichos compuestos | |
| DE69919364D1 (de) | Pyrroloindole, pyridoindole und azepinoindole als 5-ht2c agonisten | |
| PE20081504A1 (es) | Compuestos de biciclocarboxiamida sustituidos | |
| UY25873A1 (es) | Derivados de 3-azabiciclo [3.1.0] hexano útiles en terapia en afecciones mediadas por receptores opiáceos | |
| PT1284974E (pt) | Derivados de triazoliltropano como moduladores de ccr5 | |
| ES2101319T3 (es) | Analogos de la vitamina d. | |
| PE20020844A1 (es) | Derivados de imidazolilo como inhibidores del factor de liberacion de la corticotropina | |
| CO5580821A2 (es) | 4-cetolactamas y -lactonas 3-fenil-3-substituidas, espirociclicas | |
| ATE264851T1 (de) | 4-fluoralkyl-2h-benzopyrane mit antiestrogener wirksamkeit | |
| PE20061328A1 (es) | Derivados de oxadiazol o tiadiazol como inhibidores de la biosintesis de leucotrienos | |
| PE20020194A1 (es) | 2,3,7,8,9,10,11,12-OCTAHIDROAZEPINO[4,5-b]PIRANO[3,2-e)INDOLES SUSTITUIDOS | |
| TR200000058T2 (tr) | Benzotiyofen türevleri-kullanım ve terkipleri. | |
| ES471245A1 (es) | Un procedimiento para la preparacion de una composicion her-bicida a base de derivados de n'-fenil-n-metilurea | |
| DE60106242D1 (de) | Oxidative behandlung von stahlschlacken und enthaltende ld schlacke | |
| ATE372111T1 (de) | Chondroitinsulfat enthaltende zusammensetzung | |
| MA27944A1 (fr) | N-[3-(3-substituees-pyrazolo [1,5-a] pyrimidin-7-yl) - phenyl] - sulfonamides et compositions et methodes rapportees. | |
| BG104471A (en) | Benzylidene pyrazolones, their preparation and use as herbicides | |
| ATE18548T1 (de) | Pyrrolidin-derivate, herstellung und verwendung als heilmittel. | |
| PE20050862A1 (es) | Derivados de indano heterociclicos sustituidos como antagonistas de los receptores de dopamina d2 y serotonina 2a | |
| FR2868790A1 (fr) | Melange odorisant pour combustible gazeux inodore | |
| DE3171349D1 (en) | Cyclopentanol derivatives, their preparation, their application as perfume agents, the compositions in which these products are incorporated, and the intermediates obtained | |
| ATE252650T1 (de) | Entschwefelungsmischung auf basis von calciumcarbid und/oder kalk | |
| MX174141B (es) | Nuevos derivados de la 1-bencenosulfonil-2-oxo-5-alquiltio-pirrolidina y procedimiento para su preparacion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |